您的当前位置:首页 > 行业数据 > 图表13全球获批5款KRASG12C抑制剂
图片属性
图片格式:PNG 图片大小:183KB 图片尺寸:2281*937
同报告图片
 / 4
图表13全球获批5款KRASG12C抑制剂_第1页
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
图表13全球获批5款KRASG12C抑制剂_第2页
图表13全球获批5款KRASG12C抑制剂_第3页
图表13全球获批5款KRASG12C抑制剂_第4页
图表13全球获批5款KRASG12C抑制剂_第5页
所属报告: 加科思-B(01167.HK)-港股公司研究报告:专攻突破难成药靶点开发管线领先布局及专利全面搭建共筑竞争壁垒-251118(25页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠